In addition, upregulation of CPT2 has been shown to attenuate CRC tumor development and increase chemosensitivity via a hyperactive Wnt/β-catenin pathway in vivo (Liu et al., 2022). This evidence concerns the gene CPT2 and colorectal carcinoma.